SYDNEY, AUSTRALIA — Cochlear today announced it has completed recruitment for its worldwide pivotal trial program evaluating fully implantable hearing technology. Patients across Cochlear’s fully implantable hearing system research programs have experienced more than 1 million hours with their devices to date....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — enrollment completion is a trial milestone; no safety or efficacy results have been released yet.
Completion of a worldwide pivotal trial for a fully implantable cochlear implant marks a significant regulatory step that could reshape implant candidacy discussions and patient expectations if results are favorable.
- 01Cochlear has completed enrollment in its global pivotal trial for fully implantable hearing technology.
- 02Trial participants have accumulated over 1 million hours of combined device experience across all programs.
- 03This is a pivotal trial, meaning results will likely be submitted to regulators for approval consideration.
- 04No efficacy or safety outcome data have been publicly reported yet.
- 05Full implantability would eliminate external processors, a major quality-of-life differentiator for cochlear implant users.
Cochlear has completed enrollment in its worldwide pivotal trial program for fully implantable hearing technology.
press releasesupportedTrial participants have logged more than 1 million hours of experience across the research programs.
press releaseunclear